KCNA5 and pulmonary arterial hypertension: Variants in KCNA5 have also been implicated as potential modifiers in PAH pathogenesis, including in an early-onset case of severe PAH with a pathogenic BMPR2 variant [31], but this has not yet been convincingly replicated.